Skip to main content
Year archive

MBB SE — 2026 filings

All 25 regulatory filings released by MBB SE (MBB) in 2026, sourced directly from the official regulator.

25 Filings
2026 Period
2026 filings (25)
Filing Released Lang
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Regulatory Filings
2026-05-04 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-04-27 English
MBB SE: Bekanntmachung der Einberufung zur Hauptversammlung am 03.06.2026 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2026-04-24 German
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-04-20 English
Report Publication Announcement 2026
Report Publication Announcement
2026-04-15 English
MBB SE increases Share Buyback Program 2025 to 25 million and extends duration
Transaction in Own Shares
2026-04-13 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-04-10 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-04-06 English
Annual financial report 2025
Annual Report
2026-04-01 English
MBB SE reports 2025 results, proposes an increase in the base dividend to 1.21 per share and expects revenue of 1.11.2 billion with an EBITDA margin of 1518% for 2026
Earnings Release FY 2025
2026-03-31 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-03-30 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-03-23 English
Report Publication Announcement 2026
Report Publication Announcement
2026-03-20 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-03-16 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-03-09 English
Transaction in Own Shares 2026
Transaction in Own Shares
2026-03-04 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-03-02 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-02-20 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-02-16 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-02-09 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-02-02 English
MBB SE exceeds earnings forecast for fiscal year 2025 with an EBITDA margin of around 18% on revenue of 1.17 billion
Earnings Release FY 2025
2026-01-26 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-01-19 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-01-12 English
Disclosure pursuant to Art. 5 Sec. 1 lit. b) and Sec. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Sec. 2 and Sec. 3 of the Commission Delegated Regulation (EU) No 201
Transaction in Own Shares
2026-01-05 English